Substance Name: Satralizumab [USAN]
RN: 1535963-91-7
UNII: YB18NF020M
Note
- Humanized monoclonal antibody targeting the interleukin-6 receptor.
Molecular Formula
- C6340-H9776-N1684-O2022-S46 (peptide)
Classification Code
- Treatment of Neuromyelitis Optica (NMO) And Neuromyelitis Optica Spectrum Disorders (NMO-SD)
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Sapelizumab
- Satralizumab [USAN]
Synonyms
- Enspryng
- Immunoglobulin G2, anti-(human interleukin 6 receptor) (human-mus musculus monoclonal SA237 heavy chain), disulfide with human-mus musculus monoclonal SA237 light chain, dimer
- SA237
- Sapelizumab
- Sapelizumab [INN]
- Satralizumab
- Satralizumab-mwge
- UNII-YB18NF020M
Registry Numbers
CAS Registry Number
- 1535963-91-7
FDA UNII
- YB18NF020M
System Generated Number
- 1535963917